{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:57Z","timestamp":1790874897738,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["heartandlung.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.hrtlng.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T03:41:58Z","timestamp":1685677318000},"page":"136-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-4697","authenticated-orcid":false,"given":"Ada E.M.","family":"Bloem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Houben-Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my L.M.","family":"Mostard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Stoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy J.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits M.E.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.H.","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn A.","family":"Spruit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2023.05.013_bib0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/thx.2008.101691","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0003","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00408-016-9850-y","article-title":"Health-related quality of life in patients with idiopathic pulmonary fibrosis","volume":"194","author":"Yount","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0075-2018","article-title":"Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases","volume":"27","author":"Swigris","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccm.2015.08.013","article-title":"Consequences of Sarcoidosis","volume":"36","author":"Drent","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0008","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/resp.14154","article-title":"Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden","volume":"27","author":"Lancaster","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0009","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/diagnostics11061089","article-title":"Health-related quality of life (Hrqol) in sarcoidosis: diagnosis, management, and health outcomes","volume":"11","author":"Saketkoo","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0010","first-page":"1","article-title":"Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review","volume":"18","author":"Carvajalino","year":"2018","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0011","article-title":"The burden of sarcoidosis symptoms from a patient perspective","author":"Voortman","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0012","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jphys.2015.05.011","article-title":"The leicester cough questionnaire","volume":"62","author":"Ward","year":"2016","journal-title":"J Physiother"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","article-title":"Dimensional assessment of chronic fatigue syndrome","volume":"38","author":"Vercoulen","year":"1994","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0020-7489(95)00065-8","article-title":"A comparison of two methods of measuring fatigue in patients on chronic haemodialysis: visual analogue vs Likert scale","volume":"33","author":"Brunier","year":"1996","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0018","series-title":"Meten in de praktijk","author":"Beurskens","year":"2008"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0019","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/jcm9041178","article-title":"Severe fatigue is highly prevalent in patients with IPF or sarcoidosis","volume":"9","author":"Bloem","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007536","article-title":"Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the chance study","volume":"5","author":"Smid","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0021","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.rmed.2016.07.015","article-title":"Burden of COPD in patients treated in different care settings in the Netherlands","volume":"118","author":"Smid","year":"2016","journal-title":"Respir Med"},{"issue":"Suppl 3","key":"10.1016\/j.hrtlng.2023.05.013_bib0022","first-page":"5","article-title":"Lung volumes and forced ventilatory flows. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society","volume":"11","author":"Quanjer","year":"1994","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue pain intensity scale: what is moderate pain in millimetres?","volume":"72","author":"Collins","year":"2020","journal-title":"Pain Inval Date"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0024","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/hcy102","article-title":"Visual analogue scales for interstitial lung disease: a prospective validation study","volume":"111","author":"Yates","year":"2018","journal-title":"QJM: Int J Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1553-2712.2000.tb02231.x","article-title":"Clinically meaningful changes in quantitative measures of asthma severity","volume":"7","author":"Karras","year":"2000","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0026","first-page":"479","article-title":"Validation of a visual analog scale to measure dyspnea in patients with diffuse interstitial lung disease","volume":"46","author":"Ramirez-Venegas","year":"1994","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01531-2021","article-title":"The use of online visual analogue scales in idiopathic pulmonary fibrosis","volume":"59","author":"Moor","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0028","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1990"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0029","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rmed.2010.09.014","article-title":"The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis","volume":"105","author":"Hoitsma","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0032","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S2213-2600(17)30158-3","article-title":"FAntasTIGUE consortium. Fatigue in COPD: an important yet ignored symptom","volume":"5","author":"Spruit","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.04.047","article-title":"Managing fatigue in patients with interstitial lung disease","author":"Kahlmann","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0034","first-page":"76","article-title":"Exercise-based pulmonary rehabilitation for interstitial lung diseases: a review of components, prescription, efficacy, and safety","author":"Mendes","year":"2021","journal-title":"Front Rehabilit Sci"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0884-y","article-title":"Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial","volume":"19","author":"Perez-Bogerd","year":"2018","journal-title":"Respirat Res"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0036","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/thx.2007.088070","article-title":"Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease","volume":"63","author":"Holland","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0037","article-title":"Pulmonary rehabilitation for interstitial lung disease","author":"Dowman","year":"2021","journal-title":"Cochr Datab Systemat Rev"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000370126","article-title":"Principles of rehabilitation and reactivation: interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement","volume":"89","author":"Holland","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.hrtlng.2023.05.013_bib0039","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respirat Criti Care Med"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323001279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323001279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T20:46:16Z","timestamp":1716842776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956323001279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"alternative-id":["S0147956323001279"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.05.013","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}